A disruptor to Precision Medicine and Nutrition through biomarker discovery InSyBio is a privately held Company focusing, through advanced big-data computational tools, on biomarker discovery for Cancer, Neurodegenerative diseases and Nutrition. Biomarker extraction from biological big data (genomics, transcriptomics, proteomics, etc.) is essential for drug discovery & research acceleration, personalized medicine and personalized Nutrition.

Modern approaches in diagnosis, prognosis, disease progression and treatment require biomarkers from biological big data; these can only be discovered however through the utilization of bioinformatics methods and efficient big data analytics tools. Existing tools and approaches are single-task oriented, costly, and they treat different types of biomarkers (genes, RNA, proteins, clinical biomarkers etc.) using individual and not interconnected processes; thus, resulting in limited scientific deduction. Moreover, existing approaches which are mostly rely on statistical analysis, require a high number of samples for the identification of biomarkers which makes them in-applicable to early stages and Phase 1 clinical trials.

InSyBio Suite patent-pending breakthrough solution is integrated into a S/W platform (InSyBio’s) and is able to significantly speed up the biomarker discovery process by providing an end-to-end analysis process by requiring limited number of samples for the biomarker discovery phase and ending up discovering fewer biomarkers, simplifying thus the validation process. Moreover, with InSyBio’s solution, the identified biomarkers and predictive models are becoming far more accurate due to the effective combination of a minimal set of biomarkers with Artificial Intelligence models instead of using these markers unassociated.These advantages are enabled by InSyBio’s proprietary technology which offers simultaneous integration of data from different sources and types and has demonstrated ability to locate significantly more common proteins in large scale proteomics datasets. InSyBio’s solutions are based on biological networks modeling to integrate many layers of complex biological information (mutations, proteins, clinical variables, peptides etc.) and advanced big data-oriented artificial intelligence methods


Labros Digonis

Patras Science Park , Rio GR-265 04 Greece

+30 2610 994 839

stay informed!

Subscribe to receive our latest news and notifications

Evangelia Gralista

Web Design Internship

Evangelia Gralista from Trikala,Greece is in her senior year at University of Patras in the department of mathematics. She is currently working as a web design intern at Patras Science Park (PSP).

Vicky Tomara

Development Director

Vicky studied Business Administration at Athens University of Economics and Business and she got a M.B.A. from University of Patras. Her experience and background focus on supporting businesses-academia partnerships. Especially, she has been primarily activated in innovation supporting tools, while she worked in the past as an economist and research project manager in the industry. She has a good knowledge of the Greek innovation ecosystem actors, including academia, research institutes, regional and central governmental organizations, entrepreneurs and industry. She contributed to the launch and development of the Innovation and Technology Transfer Office of the University of Patras where she served as a Technology Transfer Consultant for 4 years. She acted as the principal organizational officer on behalf of the University of Patras for the 1st, 2nd and 3rd Patras IQ Innovation Exhibition. Also, she contributed to the launch and development of the Technology Transfer Office of Patras Science Park and she involved in the building of the collaborative network between both CERN procurement and CERN Technology Transfer Group with the Greek start up community & enterprises. She is currently the Development Director in Patras Science Park, she is member of the Advisory Board of the Proof of Concept and she participates in the selection committee in various regional innovation competitions.